Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
ATCHISON, Kan., June 28, 2021 (GLOBE NEWSWIRE) -- MGP Ingredients, Inc., (Nasdaq: MGPI) has named Erika Lapish Vice President of Human Resources. Lapish brings more than 20 years in global HR...
-
PETAH TIKVA, Israel, June 28, 2021 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services,...
-
7 of the 10 largest IPOs by proceeds raised listed on Nasdaq 61% of all proceeds raised through IPOs listed on Nasdaq $187 billion in market value switched to Nasdaq NEW YORK, June 28, 2021 ...
-
Radisson Hotel Group expands presence in Turkey with new hotel in Izmir, AliagaRadisson Hotel Group is proud to announce the opening of Radisson Hotel Izmir Aliaga and welcome guests to one of...
-
VANCOUVER, British Columbia, June 28, 2021 (GLOBE NEWSWIRE) -- Prime Mining Corp. (“Prime” or the “Company”) (TSX-V: PRYM, OTCQB: PRMNF, Frankfurt: 04V3) today reported new results from its ongoing...
-
Nuevo Laredo, Mexico, June 28, 2021 (GLOBE NEWSWIRE) -- Ritual Zero Proof Mexico, since its partnership with Arkay Beverages SA de CV Mexico is leading the American non-alcoholic sector since its...
-
SANTA CLARA, Calif., June 28, 2021 (GLOBE NEWSWIRE) -- ISC—NVIDIA today announced it is turbocharging the NVIDIA HGX™ AI supercomputing platform with new technologies that fuse AI with high...
-
GaN performance in NXP’s multi-chip modules for 5G infrastructure increases efficiency by 8 percentage pointsReduces size and weight of radios; accelerates the design and deployment of 5G systemsNXP...
-
Seattle, WA, June 27, 2021 (GLOBE NEWSWIRE) -- SAFR from RealNetworks, Inc. (NASDAQ: RNWK) ), a leader in high accuracy, low bias facial recognition, is pleased to announce that Axis Communications,...
-
First-ever clinical data supporting safety and efficacy of in vivo CRISPR genome editing in humans Interim readout in ongoing Phase 1 trial finds single 0.3 mg/kg dose of NTLA-2001 led to 87% mean...